Skip to content
Home » Oncology » Oncology – Testis » Radiotherapy in testis cancer

Radiotherapy in testis cancer

Classically for stage 1 seminoma – dog-leg with retroperitoneal nodes + ipsilateral pelvic nodes.

Recurrence after radiation is out of field – commonly thorax and supraclavicular fossa

Radiation 20 – 24 Gy.

Also used for GCNIS.

Acute generalised side effects:

  • Nausea and vomiting
  • Diarrhoea
  • Haematologic toxicity

Late GI side effects:

  • Chronic dyspepsia
  • Peptic ulcer disease

Scatter to contra-lateral testis can be significant despite shielding -> increased oligospermia rates.

 

Late cardiac risk and secondary malignancy are worrisome given length of survival after treatment.

Possible actuarial risk of developing secondary malignancy up to 18 % at 25 years

  • Leukaemia (both XRT and chemo)
  • Upper GI, bladder, sarcoma and possibly pancreatic cancers linked to XRT
  • NB also radiation risk due to recurrent CT scans may be a factor

 

The cardiac risk of radiation is less clear although seems to definitely be a factor for those with mediastinal irradiation. Some retrospective cohort analyses has shown an increased cardiac-specific risk even for those radiated below the diaphragm.